Shares of Gen-Probe Drop on Deal Speculation

A report on the website of The Wall Street Journal speculated that Novartis is a sole remaining bidder for Gen-Probe.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories